Is Bicara Therapeutics Inc. Common Stock (BCAX) a Buy, Sell, or Hold?
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
$28.1 USD
-$0.05 (-0.18%)
- Volume
- 0
- Average Volume
- 690.69K
- Market Capitalization
- $1.54B
- P/E Ratio
- -10.11
- Dividend Yield
- 0.00%
- Price Target
- $37.00
- Year High
- $30.99
- Year Low
- $9.57
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $13.85
| Date | EPS Estimated | Time | Revenue | Revenue Estimated |
|---|---|---|---|---|
| 2026-08-11 | -0.80 | After Market Close | $- | $- |
| 2026-05-11 | -0.64 | After Market Close | $- | $- |
| 2026-03-26 | -0.72 | After Market Close | $- | $- |
| 2025-11-10 | -0.55 | After Market Close | $- | $- |
| 2025-08-12 | -0.54 | After Market Close | $- | $- |
| 2025-05-13 | -0.40 | After Market Close | $- | $- |
| 2025-03-27 | -0.31 | After Market Close | $- | $- |
| 2024-11-12 | -0.46 | After Market Close | $- | $- |
| 2024-09-13 | After Market Close | $- | $- | |
| 2024-06-30 | After Market Close | $- | $- | |
| 2023-12-31 | After Market Close | $- | $- | |
| 2023-09-30 | After Market Close | $- | $- | |
| 2023-06-30 | After Market Close | $- | $- | |
| 2023-03-31 | After Market Close | $- | $- |